Please login to the form below

Not currently logged in
Email:
Password:

US CROs to report payments to physicians

New rules to US ‘Sunshine Act’ also apply to CMOs

US contract research organisations (CROs) and contract manufacturing organisation (CMOs) must now declare any payments made to physicians, under new federal regulations impacting the pharmaceutical industry.

The Transparency Report and Reporting of Physician Ownership or Investment Interests, commonly known as the 'Sunshine Act', will require manufacturers of drugs, devices, biological or medical supplies to report payments made to physicians on an annual basis.

The new rules fall under the Patient Protection and Affordable Care Act (ACA) section of the act and apply to companies functioning within US health programmes Medicare, Medicaid or CHIP.

The ruling, released last week, also applies to both CMOs and CROs and will cover "payments and transfers of value", including consulting fees, honoraria, gifts, travel and entertainment.

From August 2013 companies will need to begin collecting data on payments made to physicians, which will then be submitted to the Department of Health and Human Services' (HHS) Centers for Medicare and Medicaid Services (CMS), by the end of March 2014.

"The intent of this law is to bring potential conflicts of interest to light with the goal of driving down healthcare costs," explained Scott Liebman, principal at Porzio, Bromberg & Newman, speaking to Forbes.

14th February 2013

From: Research, Regulatory

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

OPEN Health attend EB World Congress—building on momentum and strength in numbers for epidermolysis bullosa
Ben Speller shares his thoughts on the value of disease specific congresses...
OPEN Health use PR to support clinical trial recruitment
International Clinical Trials Day finds clinical research in the spotlight like never before, with any news coming from the many studies into potential vaccines and treatments for SARS-CoV-2...
Covid-19: what could it mean for the diabetic population?
Steve How and Oli Hudson, of Wilmington Healthcare, assess the scale of the diabetes crisis and how coronavirus might impact on it...

Infographics